Company intelligence / Profile preview
Neopharma
Abu Dhabi, Abu Dhabi, United Arab Emiratesneopharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Manufactures and commercializes more than 100 molecules in 50 countries with five globally accredited pharmaceutical manufacturing facilities across three continents
- Therapeutic areas
- Men's HealthPulmonologyEndocrinologyWomen's HealthOtherDermatologyGastroenterologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small moleculesgenericsbranded formulationsactive pharmaceutical ingredients (APIs)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Japanese partnerships for diabetes research
Beyond the preview
Go deeper on Neopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neopharma.